|
EWSR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.384400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.543800E-02 |
| Normal-vs-Stage2 |
1.244610E-01 |
| Normal-vs-Stage3 |
2.232500E-02 |
| Normal-vs-Stage4 |
3.762500E-03 |
| Stage1-vs-Stage2 |
9.059000E-01 |
| Stage1-vs-Stage3 |
4.418200E-01 |
| Stage1-vs-Stage4 |
1.180100E-02 |
| Stage2-vs-Stage3 |
6.241800E-01 |
| Stage2-vs-Stage4 |
1.331770E-01 |
| Stage3-vs-Stage4 |
2.130400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.801600E-02 |
| Normal-vs-AfricanAmerican |
4.726400E-02 |
| Normal-vs-Asian |
5.640200E-02 |
| Caucasian-vs-AfricanAmerican |
7.818400E-01 |
| Caucasian-vs-Asian |
8.997200E-01 |
| AfricanAmerican-vs-Asian |
8.792000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.868220E-02 |
| Normal-vs-Female |
4.123200E-01 |
| Male-vs-Female |
1.195780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.376200E-02 |
| Normal-vs-Extreme_Weight |
6.078000E-02 |
| Normal-vs-Obese |
6.403800E-02 |
| Normal-vs-Extreme_Obese |
1.546030E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.056400E-01 |
| Normal_Weight-vs-Obese |
5.939800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.502800E-01 |
| Extreme_Weight-vs-Obese |
8.719800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.675400E-01 |
| Obese-vs-Extreme_Obese |
1.881780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.556800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.673400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.687500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.010500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.339400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.778400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.013050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.380800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.473400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.095600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.692400E-01 |
| Normal-VS-Type2 PRCC |
4.61789999572915E-08 |
| Normal-VS-KIRP CIMP |
3.715200E-01 |
| Normal-VS-Unclassified PRCC |
2.827800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.0749847113043E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.828600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.260300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.497900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.299450E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.749400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.297500E-03 |
| Normal-vs-N1 |
9.451800E-02 |
| Normal-vs-N2 |
7.977700E-02 |
| N0-vs-N1 |
2.644000E-01 |
| N0-vs-N2 |
5.736200E-01 |
| N1-vs-N2 |
2.743800E-01 |
|
|
